[Withdrawal and reintroduction of pharmacological treatment of epilepsy in paediatric patients. Our experience].

Introduction: There are many variables to be considered in the withdrawal of treatment for epileptic seizures, which requires a risk-benefit assessment.

Patients And Methods: A retrospective study of patients in a neuropaediatric practice who required the reintroduction of treatment for epilepsy after its initial withdrawal, and who continue to receive anti-seizure drugs.

Results: Twenty-three of 57 children whose treatment was withdrawn are currently being administered the treatment as a monotherapy.